Skip to content
Open access

326. Ketamine-induced changes of cerebral glucose metabolism in healthy humans: evidence from [18F]FDG functional PET

Sep 2026 · International Journal of Neuropsychopharmacology · Vol 29, pp. i136 - i136 · 0 citations

TL;DR

The findings provide metabolic sensitive insight into ketamine’s impact on neuronal function and synchronous, temporally dynamic metabolic changes may contribute to ketamine’s rapid-onset and transient neuropsychological effects.

Abstract

Abstract Background Ketamine is a N-methyl-D-aspartate receptor antagonist with rapid-acting antidepressant properties and characteristic dissociative side effects, yet its neuronal mechanisms remain only partially understood. Previous studies have primarily used pharmacological magnetic resonance imaging (phMRI) to characterize ketamine-induced neuronal alterations (Höflich et al., 2017; Maltbie, Kaundinya, & Howell, 2017). Allthough phMRI offer high temporal and spatial resolution, neuronal activity is assessed indirectly via oxygen metabolism, and neurovascular factors (Doyle et al., 2013; J.L. Reed et al., 2019). In contrast, functional PET (fPET) with [18F]Fluorodeoxyglucose ([18F]FDG) offer a complementary and direct measure (Leybaert, 2005), to quantify cerebral glucose metabolism. Previous studies using [18F]FDG PET to investigate ketamine’s neurophysiological effect, have been restricted to static metabolic rates (Vollenweider et al., 1997), thereby being unable to assess its dynamic effects. Aims & Objectives We aimed to capture acute ketamine-induced changes in cerebral glucose metabolism within a functional PET (fPET) framework. Method In this double-blind, randomized, cross-over study twenty-three healthy volunteers (mean age ± SD = 25.48 ± 4.08 years, 14 male) underwent two 75-minute [18F]FDG simultaneous PET/MR scans, during which they received either 0.25mg*kg-1 (S)-ketamine or a 0.9% saline placebo intravenously. 20 minutes after tracer application and fPET acquisition start, the study drug was administred following a block design comprising three 5-minutes infusion blocks separated by 10-minute drug-free intervals. fPET data were reconstructed into 30 seconds frames and preprocessed as described previously (M.B. Reed et al., 2024). Baseline-corrected [18F]FDG time activity curves were obtained across grey-matter voxels, capturing drug-induced changes in cerebral glucose metabolism, and used for a voxel-wise intersubject correlation analysis, and subsequent comparison between conditions in a repeated measures ANOVA (p < 0.05, FWE-corrected). Results Ketamine induced widespread and significantly increased cortical intersubject correlations, most predominantly in frontal cortical regions and the right hippocampus. The nine most significant regions and highest T-values are displayed in the Table below. Discussion & Conclusions (S)-Ketamine administration elicited metabolic responses primarily within hubs of the default mode and frontoparietal control network, with additional but fewer clusters in regions associated with the visual, sensorimotor and salience networks. These synchronous, temporally dynamic metabolic changes may contribute to ketamine’s rapid-onset and transient neuropsychological effects. In summary, our findings provide metabolic sensitive insight into ketamine’s impact on neuronal function.

Read PDF

Similar papers

Open access Sep 2026

Pharmacological and non-pharmacological modulation of striatal dopamine release: a meta-analysis of [11C]raclopride PET studies.

The dopaminergic system has long been a central focus of functional neuroimaging. Positron emission tomography (PET) with the D2/D3 receptor radioligand [11C]raclopride remains the most widely used method for indirectly quantifying striatal dopamine release in vivo. However, no previous meta-analysis has studied the re...

Mikael Eklund, Eman Hassanain, T. Vahlberg et al. · 0 citations
Open access Sep 2026

A multimodal investigation of altered cortical metabolism in patients with disorders of consciousness

Disorders of consciousness (DoC) are characterised by marked reductions in cerebral glucose metabolism, but the specific cellular and neurochemical processes driving this impairment remain unclear. To elucidate these mechanisms, a multimodal imaging approach combining [18F]-fluorodeoxyglucose positron emission tomograp...

N. W. Duncan, L. Huang, C. Lee et al. · 0 citations
Open access Sep 2026

451. Investigating synaptic density in youth with cannabis use: preliminary findings from a [18F]SynVesT-1 PET imaging study

The pilot findings do not support a difference in synaptic density in youth that use cannabis regularly compared to those who do not, suggesting that lower synaptic density may be related to more chronic, long-term use of cannabis.

C. Côté, M. Zilberman, S. S. Dheda et al. · 0 citations
Review Open access Sep 2026

Modulation of GABA and Glutamate by Ketamine in Depression: A Systematic Review and Meta-Analysis of Magnetic Resonance Spectroscopy Studies

Rigorous RCTs with standardized protocols, larger sample sizes, uniform dosing, and systematic biomarker investigations are needed to clarify ketamine’s neurochemical mechanism and optimize ketamine’s clinical application in treatment-resistant depression.

Balwinder Singh, Hossam M. Ali, Alessandro Miola et al. · 0 citations
Open access Aug 2026

Age-Related Decline in Anterior Cingulate and Medial Prefrontal Metabolism in Nonneurodegenerative Patients: An 18 F-FDG PET Study

Investigating age-related regional metabolic changes in individuals undergoing brain FDG PET imaging without evidence of neurodegenerative disease supports region-specific metabolic vulnerability during normal aging while highlighting substantial interindividual variability in cerebral glucose metabolism.

Reyhan Toyran, Yiğithan Okar, Ayşe Rana Ovut et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.